Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials-Reference-Cited by-同舟云学术

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

Published:2016-01 Issue:1 Volume:64 Page:19-28
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Dore Gregory J.,Conway Brian,Luo Yan,Janczewska Ewa,Knysz Brygida,Liu Yan,Streinu-Cercel Adrian,Caruntu Florin Alexandru,Curescu Manuela,Skoien Richard,Ghesquiere Wayne,Mazur Włodzimierz,Soza Alejandro,Fuster Francisco,Greenbloom Susan,Motoc Adriana,Arama Victoria,Shaw David,Tornai Istvan,Sasadeusz Joseph,Dalgard Olav,Sullivan Danielle,Liu Xuan,Kapoor Mudra,Campbell Andrew,Podsadecki Thomas

Publisher

Elsevier BV

Subject

Hepatology

Reference31 articles.

1. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

2. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

3. Incivek (telaprevir) film coated tablets: US prescribing information,2013

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19

2. A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical Institute, Bucharest, Romania;Medical Science Monitor;2022-06-23

3. Breakthroughs in hepatitis C research: from discovery to cure;Nature Reviews Gastroenterology & Hepatology;2022-05-20

4. Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy;PeerJ;2021-09-17

5. Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study;Journal of Gastrointestinal and Liver Diseases;2021-03-13